This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Guthmann, J.-P. Articles by Olliaro, P. Search for Related Content PubMed PubMed Citation Articles by Guthmann, J.-P. Articles by Olliaro, P.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, November 2006, p. 3734-3739, Vol. 50, No. 11
0066-4804/06/$08.00+0     doi:10.1128/AAC.01618-05
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Methodological Issues in the Assessment of Antimalarial Drug Treatment: Analysis of 13 Studies in Eight African Countries from 2001 to 2004

Jean-Paul Guthmann,^1* Loretxu Pinoges,¹ Francesco Checchi,^1,2 Simon Cousens,² Suna Balkan,³ Michel van Herp,⁴ Dominique Legros,^1,5 and Piero Olliaro^6,7

Epicentre, Paris, France,¹ Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom,² Médecins Sans Frontières, Paris, France,³ Médecins Sans Frontières, Brussels, Belgium,⁴ Risk Assessment and Field Operations, CSR Office of Alert and Response Operations, WHO, Geneva, Switzerland,⁵ UNICEF/UNDP/World Bank/WHO Special Programme on Research and Training in Tropical Diseases (TDR), Geneva, Switzerland,⁶ University of Oxford, Centre for Tropical Medicine and Vaccinology, Churchill Hospital, United Kingdom⁷

Received 21 December 2005/ Returned for modification 9 February 2006/ Accepted 30 August 2006

The objectives of these analyses were to assess the feasibility of the latest WHO recommendations (28-day follow-up with PCR genotyping) for the assessment of antimalarial drug efficacy in vivo and to examine how different statistical approaches affect results. We used individual-patient data from 13 studies of uncomplicated pediatric falciparum malaria conducted in sub-Saharan Africa, using chloroquine (CQ), sulfadoxine/pyrimethamine (SP), or amodiaquine (AQ). We assessed the use effectiveness and test performance of PCR genotyping in distinguishing recurrent infections. In analyzing data, we compared (i) the risk of failure on target days (days 14 and 28) by using Kaplan-Meier and per-protocol evaluable patient analyses, (ii) PCR-corrected results allowing (method 1) or excluding (method 2) new infections, (iii) and day 14 versus day 28 results. Of the 2,576 patients treated, 2,287 (89%) were evaluable on day 28. Of the 695 recurrences occurring post-day 14, 650 could be processed and 584 were resolved (PCR use effectiveness, 84%; test performance, 90%). The risks of failure on day 28 with Kaplan-Meier and evaluable-patient analyses tended to be generally close (except in smaller studies) because the numbers of dropouts were minimal, but attrition rates on day 28 were higher with the latter method. Method 2 yielded higher risks of failure than method 1. Extending observation to 28 days produced higher estimated risks of failure for SP and AQ but not for CQ (high failure rates by day 14). Results support the implementation of the current WHO protocol and favor analyzing PCR-corrected outcomes by Kaplan-Meier analysis (which allows for dropouts) and retaining new infections (which minimizes losses).

---

* Corresponding author. Mailing address: Epicentre, 8 rue Saint Sabin, 75011 Paris, France. Phone: (33) 140 21 28 06. Fax: (33) 140 21 28 03. E-mail: jguthmann{at}epicentre.msf.org.

Published ahead of print on 5 September 2006.

---

Antimicrobial Agents and Chemotherapy, November 2006, p. 3734-3739, Vol. 50, No. 11
0066-4804/06/$08.00+0     doi:10.1128/AAC.01618-05
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

This article has been cited by other articles:

• Baird, J. K. (2009). Resistance to Therapies for Infection by Plasmodium vivax. Clin. Microbiol. Rev. 22: 508-534 [Abstract] [Full Text]  
• Greenhouse, B., Dokomajilar, C., Hubbard, A., Rosenthal, P. J., Dorsey, G. (2007). Impact of Transmission Intensity on the Accuracy of Genotyping To Distinguish Recrudescence from New Infection in Antimalarial Clinical Trials. Antimicrob. Agents Chemother. 51: 3096-3103 [Abstract] [Full Text]